Discover
HRMY
Harmony Biosciences Holdings, Inc.
39.19
1 x 39.21
3 x 39.25
bid
ask
+
0.19
0.49%
02:54 PM
timesize
| Ytd | 4.73% | |
| 1y | 12.61% |
38.88
day range
39.41
25.52
52 week range
40.87
| Open | 39.02 | Prev Close | 39.00 | Low | 38.88 | High | 39.41 | Mkt Cap | 2.27B |
| Vol | 266.99K | Avg Vol | 840.91K | EPS | 3.08 | P/E | 12.74 | Forward P/E | 5.74 |
| Beta | 0.96 | Short Ratio | 6.40 | Inst. Own | 100.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 35.19 | 200-d Avg | 33.40 | 1yr Est | 46.10 |
| Income Statement | |||
| Total Revenue | 261.28M | ||
| Revenues (USD) | 261.28M | ||
| Cost of Revenue | 63.20M | ||
| Gross Profit | 198.08M | ||
| Operating Expenses | 108.77M | ||
| Research and Development Expense | 46.60M | ||
| Selling, General and Administrative Expense | 62.17M | ||
| Operating Income | 89.32M | ||
| Interest Expense | 3.07M | ||
| Income Tax Expense | 17.83M | ||
| Net Income | 75.43M | ||
| Net Income Common Stock | 75.43M | ||
| Net Income Common Stock (USD) | 75.43M | ||
| Consolidated Income | 75.43M | ||
| Earnings per Basic Share | 1.30 | ||
| Earnings per Basic Share (USD) | 1.30 | ||
| Earnings per Diluted Share | 1.28 | ||
| Earning Before Interest & Taxes (EBIT) | 96.34M | ||
| Earning Before Interest & Taxes (USD) | 96.34M | ||
| Weighted Average Shares | 57.93M | ||
| Weighted Average Shares Diluted | 58.76M | ||
| Balance Sheet | |||
| Cash and Equivalents | 549.77M | ||
| Cash and Equivalents (USD) | 549.77M | ||
| Investments | 412.69M | ||
| Investments Current | 118.02M | ||
| Investments Non-Current | 294.67M | ||
| Trade and Non-Trade Receivables | 111.00M | ||
| Current Assets | 814.33M | ||
| Total Assets | 1.37B | ||
| Debt Current | 20.00M | ||
| Total Debt | 153.96M | ||
| Current Liabilities | 234.07M | ||
| Debt Non-Current | 133.96M | ||
| Total Liabilities | 373.84M | ||
| Accumulated Retained Earnings (Deficit) | 268.82M | ||
| Accumulated Other Comprehensive Income | -727.00K | ||
| Shareholders Equity | 999.24M | ||
| Shareholders Equity (USD) | 999.24M | ||
| Assets Non-Current | 558.75M | ||
| Total Debt (USD) | 153.96M | ||
| Goodwill and Intangible Assets | 77.50M | ||
| Inventory | 6.36M | ||
| Liabilities Non-Current | 139.77M | ||
| Trade and Non-Trade Payables | 21.68M | ||
| Tax Assets | 156.76M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.97M | ||
| Net Cash Flow from Financing | -558.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -39.63M | ||
| Issuance (Purchase) of Equity Shares | 5.52M | ||
| Issuance (Repayment) of Debt Securities | -5.00M | ||
| Net Cash Flow from Investing | -131.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -131.50M | ||
| Net Cash Flow from Operations | 92.43M | ||
| Share Based Compensation | 9.58M | ||